FDA Inspection 1274884 — Shandong Lukang Shelile Pharmaceutical Co., Ltd.
The FDA completed an inspection of Shandong Lukang Shelile Pharmaceutical Co., Ltd. on May 30, 2025 in Jining. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Veterinary.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- May 30, 2025
- Fiscal Year
- 2025
- Product Type
- Veterinary
- Project Area
- Monitoring of Marketed Animal Drugs, Feed, and Devices
- Location
- Jining (China)